Skip to main content

Compare Stocks

Date Range: 

 LongeveronVerseonHelix BioPharmaImmunoPrecise AntibodiesCircassia Group
SymbolNASDAQ:LGVNLON:VSNTSE:HBPCVE:IPALON:CIR
Price Information
Current Price$5.30GBX 74C$0.92C$9.50GBX 34.50
52 Week RangeN/AN/AN/AN/AN/A
MarketRank™
Overall Score0.00.50.50.40.9
Analysis Score0.00.00.00.00.0
Community Score0.02.42.31.92.8
Dividend Score0.00.00.00.00.0
Ownership Score0.00.00.00.01.7
Earnings & Valuation Score0.00.00.00.00.0
Analyst Ratings
Consensus RecommendationN/AN/AN/AN/AN/A
Consensus Price TargetN/AN/AN/AN/AN/A
% Upside from Price TargetN/AN/AN/AN/AN/A
Trade Information
Market Cap$100.47 million£127.41 millionC$129.84 millionC$123.03 million£144.28 million
BetaN/AN/AN/AN/AN/A
Average Volume833,58675,33442,13358,771969,743
Sales & Book Value
Annual RevenueN/AN/AN/AC$17.18 million£23.90 million
Price / SalesN/AN/AN/A10.556.04
CashflowN/AGBX 11.19 per shareC$0.03 per shareC$0.83 per shareGBX 2.11 per share
Price / CashN/A6.6131.0311.4316.32
Book ValueN/AGBX 21 per shareC$0.03 per shareC$1.88 per shareGBX 16.60 per share
Price / BookN/AN/AN/A5.040.02
Profitability
Net IncomeN/AN/AN/AN/AN/A
EPSN/AGBX (14.30)C($0.06)C($0.21)GBX (8.80)
Trailing P/E Ratio0.00N/AN/AN/AN/A
Forward P/E Ratio
P/E GrowthN/AN/AN/AN/AN/A
Net MarginsN/AN/AN/AN/AN/A
Return on Equity (ROE)N/AN/AN/AN/AN/A
Return on Assets (ROA)N/AN/AN/AN/AN/A
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity RatioN/A74.84%1.78%11.37%2.42%
Current RatioN/A3.36%3.95%3.39%1.11%
Quick RatioN/A3.09%3.63%2.88%0.89%
Ownership Information
Institutional Ownership PercentageN/AN/AN/AN/AN/A
Insider Ownership PercentageN/AN/AN/AN/AN/A
Miscellaneous
Employees12N/A10N/A162
Shares Outstanding18.96 million151.67 million141.13 million19.08 million418.20 million
Next Earnings Date8/13/2021 (Estimated)N/A7/29/2021 (Estimated)8/27/2021 (Estimated)6/14/2021 (Estimated)
OptionableNot OptionableNot OptionableOptionableNot OptionableOptionable
SourceHeadline
Allergy Immunotherapy Market Analyzed by Top 5 Key Players by Size, revenue and Forecasts To 2027Allergy Immunotherapy Market Analyzed by Top 5 Key Players by Size, revenue and Forecasts To 2027
openpr.com - May 10 at 2:05 PM
Circassia Pharmaceuticals plc (CIRCI)Circassia Pharmaceuticals plc (CIRCI)
uk.investing.com - April 29 at 6:40 PM
Circassia Group (LON:CIR) Trading Up 5.6%Circassia Group (LON:CIR) Trading Up 5.6%
americanbankingnews.com - April 28 at 12:22 AM
Circassia Group Plc - Annual Report and Notice of AGMCircassia Group Plc - Annual Report and Notice of AGM
proactiveinvestors.co.uk - April 21 at 8:49 AM
Circassia Group Plc - Director/PDMR ShareholdingCircassia Group Plc - Director/PDMR Shareholding
proactiveinvestors.co.uk - April 10 at 1:24 PM
How Much Did Circassia Groups(LON:CIR) Shareholders Earn From Share Price Movements Over The Last Five Years?How Much Did Circassia Group's(LON:CIR) Shareholders Earn From Share Price Movements Over The Last Five Years?
finance.yahoo.com - April 5 at 8:15 AM
Global Allergy Immunotherapies Market (2021 to 2026) - Industry Trends, Share, Size, Growth, Opportunity and ForecastsGlobal Allergy Immunotherapies Market (2021 to 2026) - Industry Trends, Share, Size, Growth, Opportunity and Forecasts
marketwatch.com - March 24 at 3:47 PM
Circassia Group enters subscription agreements to raise £5 millionCircassia Group enters subscription agreements to raise £5 million
stockmarketwire.com - March 24 at 10:46 AM
Circassia narrows annual losses on cost cuts; sees early signs of recoveryCircassia narrows annual losses on cost cuts; sees early signs of recovery
stockmarketwire.com - March 24 at 5:45 AM
Circassia Group Plc - Subscription to raise £5 millionCircassia Group Plc - Subscription to raise £5 million
proactiveinvestors.co.uk - March 24 at 5:45 AM
Drone strike on Riyadh oil refinery claimed by Houthis causes fireDrone strike on Riyadh oil refinery claimed by Houthis causes fire
in.finance.yahoo.com - March 21 at 2:03 PM
Rockefeller Capital Management Continues Growth of Private Wealth Business, Announces Inaugural Team in OhioRockefeller Capital Management Continues Growth of Private Wealth Business, Announces Inaugural Team in Ohio
sg.finance.yahoo.com - March 21 at 2:03 PM
Circassia Group Plc (82C.F)Circassia Group Plc (82C.F)
ca.finance.yahoo.com - March 17 at 2:30 PM
Allergy Immunotherapy Market Analysis by Key Players & Industry Size 2027Allergy Immunotherapy Market Analysis by Key Players & Industry Size 2027
openpr.com - March 10 at 1:21 PM
Specialist respiratory outreach: a case-finding initiative for identifying undiagnosed COPD in primary careSpecialist respiratory outreach: a case-finding initiative for identifying undiagnosed COPD in primary care
nature.com - February 14 at 12:54 AM
Circassia Group Plc - PDMR Dealing - Transfer for Nil ConsiderationCircassia Group Plc - PDMR Dealing - Transfer for Nil Consideration
proactiveinvestors.co.uk - February 4 at 12:43 PM
How Much Of Circassia Group Plc (LON:CIR) Do Insiders Own?How Much Of Circassia Group Plc (LON:CIR) Do Insiders Own?
finance.yahoo.com - February 4 at 12:43 PM
Circassia Group Plc - Total Voting RightsCircassia Group Plc - Total Voting Rights
proactiveinvestors.co.uk - January 31 at 2:17 AM
Circassia Group Plc - Trading UpdateCircassia Group Plc - Trading Update
proactiveinvestors.co.uk - January 12 at 2:53 PM
Circassias Niox Revenue Dips As Pandemic Restricts Routine TestingCircassia's Niox Revenue Dips As Pandemic Restricts Routine Testing
lse.co.uk - January 12 at 9:48 AM
Circassia lowers earnings breakeven point after restructuring; annual revenue fallsCircassia lowers earnings breakeven point after restructuring; annual revenue falls
stockmarketwire.com - January 12 at 4:47 AM
Circassia Group PLCCircassia Group PLC
barrons.com - December 31 at 12:53 AM
Chronic Obstructive Pulmonary Disease (COPD) Pipeline Review, H2 2020 - Therapeutic Analysis Report Featuring 50+ Companies - ResearchAndMarkets.comChronic Obstructive Pulmonary Disease (COPD) Pipeline Review, H2 2020 - Therapeutic Analysis Report Featuring 50+ Companies - ResearchAndMarkets.com
morningstar.com - November 24 at 7:06 PM
Eurasia Mining PLC - Price Monitoring ExtensionEurasia Mining PLC - Price Monitoring Extension
proactiveinvestors.co.uk - October 4 at 5:31 PM
Eurasia Mining PLC - Second Price Monitoring ExtnEurasia Mining PLC - Second Price Monitoring Extn
proactiveinvestors.co.uk - October 4 at 7:18 AM
DateCompanyBrokerageAction
6/16/2020Circassia GroupPeel HuntReiterated Rating
6/16/2020Circassia GroupFinnCapReiterated Rating
10/15/2019Circassia GroupPeel HuntReiterated Rating
(Data available from 5/15/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.